← Leaderboards
Andrew J Levine
University Of California Los Angeles
$2,813,181
Attributed
$4,774,019
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $651.6K · FY2008–19$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$4,774,019 · 7
By mechanism
R01$3,125,322 · 2
R21$1,240,697 · 3
R03$408,000 · 2
Top collaborators
- Steve Horvath7 shared
- David J Moore5 shared
- Jacqueline Hoare2 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Roger Detels$99,398,401
- Otoniel Martinez-Maza$22,455,072
- Jerzy W. Kupiec-Weglinski$24,134,558
- Jesus Antonio Araujo$8,247,283
- Jordan E Lake$7,445,781
Others in their field
Top investigators on “Neurocognitive Deficit”
- Raquel E Gur · University Of Pennsylvania$35,329,279
- Rose A Gubitosi-Klug · Case Western Reserve University$25,240,378
- David J Volsky · St. Luke'S-Roosevelt Inst For Hlth Scis$21,344,745
- Seble G Kassaye · University Of Miami School Of Medicine$20,625,482
- Tracy A Glauser · Children'S Hospital Med Ctr (Cincinnati)$19,517,752
- Russell E Ware · Duke University$18,466,884
Research focus
Neurocognitive DeficitBrainNeurocognitiveLeadAffectCohortPharmaceutical PreparationsGenesResourcesSeveritiesAnti-Retroviral AgentsBaseCohort StudiesPharmacologic SubstanceAlcohol Or Other Drugs UseGenotypePhenotypeAdultPrevalenceChronicGeneticImpairmentDementiaPathogenesis
Grant awards (20)
Bardoxolone: a novel treatment for HIV-associated neurocognitive disorders$195,577
R21 · FY2019 · MH · contact PI
Causes and consequences of suboptimal cognitive effort in the MACS$78,000
R03 · FY2019 · NS · contact PI
Bardoxolone: a novel treatment for HIV-associated neurocognitive disorders$248,765
R21 · FY2018 · MH · contact PI
Causes and consequences of suboptimal cognitive effort in the MACS$78,000
R03 · FY2018 · NS · contact PI
Epigenetic and Psychosocial Drivers of NeuroHIV in HIV+ South African Adolescents$236,438
R21 · FY2017 · MH · contact PI
A multi-systems study of HIV neuropathogenesis: genetics-neuropathology-behavior$322,650
R01 · FY2016 · MH · contact PI
Cross-tissue study of an accelerated epigenetic aging mechanism caused by HIV$192,500
R21 · FY2016 · AG
Epigenetic and Psychosocial Drivers of NeuroHIV in HIV+ South African Adolescents$136,417
R21 · FY2016 · MH · contact PI
A multi-systems study of HIV neuropathogenesis: genetics-neuropathology-behavior$322,650
R01 · FY2015 · MH · contact PI
Cross-tissue study of an accelerated epigenetic aging mechanism caused by HIV$231,000
R21 · FY2015 · AG
A multi-systems study of HIV neuropathogenesis: genetics-neuropathology-behavior$322,650
R01 · FY2014 · MH · contact PI
Pathways to HIV-Associated Neurocognitive Disorders: A Systems Biology Approach$305,550
R01 · FY2014 · DA · contact PI
A multi-systems study of HIV neuropathogenesis: genetics-neuropathology-behavior$309,744
R01 · FY2013 · MH · contact PI
Pathways to HIV-Associated Neurocognitive Disorders: A Systems Biology Approach$293,328
R01 · FY2013 · DA · contact PI
A multi-systems study of HIV neuropathogenesis: genetics-neuropathology-behavior$322,650
R01 · FY2012 · MH · contact PI
Pathways to HIV-Associated Neurocognitive Disorders: A Systems Biology Approach$305,550
R01 · FY2012 · DA · contact PI
Pathways to HIV-Associated Neurocognitive Disorders: A Systems Biology Approach$305,550
R01 · FY2011 · DA · contact PI
Pathways to HIV-Associated Neurocognitive Disorders: A Systems Biology Approach$315,000
R01 · FY2010 · DA · contact PI
The impact of host genetics and stimulant use on neurocognition in HIV+ adults.$126,000
R03 · FY2009 · DA · contact PI
The impact of host genetics and stimulant use on neurocognition in HIV+ adults.$126,000
R03 · FY2008 · DA · contact PI